Effect of sylimarin in treatment of fatty liver
Not Applicable
- Conditions
- non alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classified Nonalcoholic fatty liver disease (NAFLD)
- Registration Number
- IRCT2016080614882N4
- Lead Sponsor
- Vice Chancellor for Research of Shahrekord University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Inclusion criteria : Obese or overweight child and adolescent with sonographic finding of
fatty liver
Exclusion criteria: Age less than 5 and more than 16 years old; patients with metabolic syndromes; viral hepatitis; wilson disease; auto immune hepatitis; juvenile hemochromatosis and other underlying diseases; allergy or intolerance to medication
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Grading of fatty liver in sonography. Timepoint: At arrival to study and 12 weeks later. Method of measurement: Sonographic grading.
- Secondary Outcome Measures
Name Time Method iver enzymes, transaminases. Timepoint: At arrival and after 12 weeks. Method of measurement: Serum.